Weisenberger, D., Liang, G., & Lenz, H. (2017). DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies. Oncogene.
Stile di citazione ChicagoWeisenberger, DJ, G. Liang, e H-J Lenz. "DNA Methylation Aberrancies Delineate Clinically Distinct Subsets of Colorectal Cancer and Provide Novel Targets for Epigenetic Therapies." Oncogene 2017.
Citazione MLAWeisenberger, DJ, G. Liang, e H-J Lenz. "DNA Methylation Aberrancies Delineate Clinically Distinct Subsets of Colorectal Cancer and Provide Novel Targets for Epigenetic Therapies." Oncogene 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.